Design and quality of life in patients who are victims of cerebral vascular accident
Transcript of Design and quality of life in patients who are victims of cerebral vascular accident
Poster Presentations P2 P329
a ligand on AChE (enzyme kinetics). Results: The phytoconstituent of ethyl
acetate extract of C. asiatica in HPLC revealed the abundant presence of a tri-
terpene: asiatic acid. The IC50 value of asiatic acid on AChE was 85mM. Asi-
atic acid do not have cytotoxic effect as revealed by MTT assay. Under stress,
the AChE activity in hippocampus cell line is increased concomitant to neurite
formation results in decreased viability of cells. Asiatic acid reverse the above
phenomena so that viability of cells restored. Conclusions: The study re-
vealed the asiatic acid as a potent inhibitor of AChE, further it did not show
any cytotoxicity on hippocampus cell line. The report of asiatic acid as a cog-
nitive enhancer, use of AChE inhibitors in the ailment of AD for symptomatic
memory restoration together with our finding asiatic acid inhibition on AChE,
suggest the possible use of asiatic acid as a drug of choice in AD treatment.
Thus this study finds the phytoconstituent asiatic acid as a potential template
for designing new, selective and powerful anti - Alzheimer’s drugs.
P2-234 THE INTERACTIONS OF TROSPIUM AND
GALANTAMINE WITH LATE ONSET ALZHEIMER
DISEASE AND URINARY INCONTINENCE
Ahmet Turan Isik, Ergun Bozoglu, Turgay Celik, Huseyin Doruk, Gulhane
School of Medicine, Ankara, Turkey. Contact e-mail: [email protected]
Background: Cholinesterase inhibitors for the treatment of Alzheimer’s Dis-
ease (AD) and antimuscarinic agents for the treatment of urge urinary inconti-
nence (UUI) may reduce the potential effect of each other in the patients with
both diseases. Trospium has a relatively low lipophilicity and low CNS pene-
tration, and galantamine, a cholinesterase inhibitors, has also allosterically
modulates nicotinic cholinergic receptors. This study was designed to evaluate
the effects of dual use of trospium and galantamine in the elderly patients with
AD and UUI. Methods: One hundred and seventy eight elderly patients: 99
UUI patients (Group I, treated with trospium), 43 AD patients (Group II, treated
with galantamine) and 36 AD and UUI patients (Group III, treated with galant-
amine and trospium) were evaluated by geriatric assessments, the Global Per-
ception Index (GPI), Patients’ Satisfaction Question (PSQ), Estimated Patients’
Improvement (EPI), nocturia and pads/day at baseline and in the 6th month.
Results: Trospium increased the satisfaction of the patients in Groups I and
III according to the EPI, PSQ, GPI, number of nocturia and pads/day. Decreas-
ing in the GDS score was significant in the Group I and III (p<0.05). Decreasing
in the ADL score was significant in the Group III (p<0.05). The MMSE scores
were not significantly changed in the all groups during the 6 months.
Conclusions: Consequently, we have thought that a combination of trospium
and galantamine could be recommended for the management of the elderly
patients with UUI and AD, which are common problems in the elderly.
P2-235 THE ROLE OF STEROID SULFATASE INHIBITION
IN RATS WITH LOSS OF SEPTAL-HIPPOCAMPAL
CHOLINERGIC NEURONS: EFFECTS ON
HIPPOCAMPAL MUSCARINIC RECEPTOR
FUNCTION AND ALPHA-SECRETASE ENZYME
ACTIVITY
Vedavalli N. Pokala1, David A. Johnson2, 1Pacific University Oregon,
Hillsboro, OR, USA; 2Duquesne University, Pittsburgh, PA, USA.Contact e-mail: [email protected]
Background: Cholinergic hypofunction of the basal forebrain is a hallmark of
Alzheimer’s disease. Basal forebrain structures have cholinergic neurons that
project to areas of the brain associated with learning and memory eg. hippocam-
pus. The current study investigates the effect of cholinergic hypofunction on the
hippocampal muscarinic receptor function and hippocampal alpha and beta sec-
retase enzyme activity in rats. Neurosteroids such as dehydroepiandrosterone
sulfate (DHEAS), modulate cholinergic-muscarinic tone in the hippocampus.
Steroid sulfatase inhibitors (SSI) can enhance hippocampal acetylcholine
(ACh) by increasing DHEAS concentation. DU-14, a SSI was used to study
the effect of hippocampal cholinergic function and secretase enzyme levels.
The goal of the current study was to investigate the effect of selective cholinergic
lesion of the septal-hippocampal pathway and steroid sulfatase inhibition on
muscarinic receptor-coupled G protein activation. Methods: Male Sprague-
Dawley rats (275-300 g) were used in the study. Artifical cerebrospinal fluid
1 ul (sham control); or the selective cholinergic immunotoxin, 192 IgG-saporin
(SAP; 0.22 ug/ul) was infused through a stainless steel cannula placed in the me-
dial septum. DU-14 (30 mg/kg) or corn oil (1 ml/kg) was injected IP 8 days fol-
lowing SAP treatment. Measurement of agonist-stimulated 35[S] GTPgS
binding was used as to measure of muscarinic receptor activation. A secretase
enzyme activity assay was performed by the addition of a secretase-specific pep-
tide conjugated to the reporter molecules EDANS and DABCYL.The level of
secretase enzymatic activity in the membrane lysate was proportional to thefluo-
rometric reaction. Results: Decreased cholinergic enervation of the hippocam-
pus resulted in increased muscarinic receptor density but decreased imuscarinic
receptor sensitivity to activation. Further, there was a decrease in a-secretase en-
zyme activity in rats with cholinergic lesion. Inhibition of steroid sulfatase had
no effect enzyme activity in this model. Conclusions: The results support the
role of hippocampal muscarinic tone in modulating amyloid precursor protein
metabolism and suggests that enhancing excitatory neurosteroid concentrations
would not be an effective approach to decreasing beta-amyloid synthesis.
P2-236 DESIGN AND QUALITY OF LIFE IN PATIENTS WHO
ARE VICTIMS OF CEREBRAL VASCULAR
ACCIDENT
Rita de Cassia G. Marques1, Renne P. Alegria2, Ana A. Francisquetti3,1AACD- Association for the Welfare of the Handicapped Children, Sao
Paulo, Brazil; 2Faculty of Psychology of the University of Sao Paulo, SaoPaulo, Brazil; 3AACD- Association for the Welfare of the Handicapped
Children, Sao Paulo, Brazil. Contact e-mail: [email protected]
Background: The present study used the designs of self-portrait of patients
who are victims of Cerebral Vascular Accident as a way of stimulating cog-
nitive functions like perception, action, emotion, language, learning and
memory, in order to improve the quality of life of patients who suffered brain
damage.Formal aspects were analyzed: line, detail, size, rotation, use of
space, asymmetry, perseveration and gestalt.Then this work aims to compare
and analyze the formal aspects of self-portrait design and the replies of the
questionnaire of quality of life (SF-36) at the beginning and at the end of
the therapeutic workshop. Methods: Five patients victims of cerebral vascu-
lar accident, aged 55 to 68, three with ischemic vascular accident and two with
hemorrhagic accident vascular were assessed.Designs of the self-portrait
were done and the replies to the questionnaire of quality of life (SF-36)
were applied at the beginning and the end of the therapeutic workshop at
AACD. Results: There were improvements in all the items of the formal anal-
yses of the design of the self-portrait of the patients of the sample. 20% im-
proved the regular line, 40% made more details in the design and increased
their size, there was no more rotation, 60% showed improvement in the use
of the space, decrease of asymmetry in 20% of the lines, there was no more
perseveration and there was increase in the Gestalt in 20% of the designs.
Conclusions: Thus, we verify that in all the domains of questionnaire of qual-
ity of life (SF- 36) there was improvement in the patients, except in the item
pain. Therefore, we conclude that the repetitive stimulus in patients with brain
injury can help in the improvement of attention, memory, planning, perfor-
mance of the design and quality of life providing satisfaction in each end of
a work of art as it was seen in the making of the self-portrait.
P2-237 INCREASE HEALTH BURDEN IN THE
ASSOCIATION OF DEPRESSIVE SYMPTOMS IN
THE ELDERLY
Francine N. Ferreira1, Karol Casagrande Crepaldi1, Claudia Santana1,
Arthur Guerra Andrade1,2, Tania Correa de Toledo Ferraz Alves1,2, 1ABCregion Medical School, Santo Andre, Brazil; 2Associated Professor Uni-
versity of Sao Paulo Medical School, Sao Paulo Medical School, Brazil.
Contact e-mail: [email protected]
Background: Vascular factors, such as hypertension, atherosclerosis, and
type 2 diabetes are frequent seen in the elderly, and cognitive impairment as-
sociated to those factors are highly incapacitating. The presence of comorbid
depressive symptoms can also magnify the cognitive deficits and increase the
burden of dementia in the elderly. Methods: Local ethics committees
approved the study, and written informed consent was obtained from all sub-
jects after a complete description of the study. All subjects underwent a clin-
ical, neuropsychological, psychiatric, and socio-demographic evaluation,